A citation-based method for searching scientific literature

Debbie Saslow, Carla Boetes, Wylie Burke, Steven Harms, Martin O Leach, Constance D Lehman, Elizabeth Morris, Etta Pisano, Mitchell Schnall, Stephen Sener, Robert A Smith, Ellen Warner, Martin Yaffe, Kimberly S Andrews, Christy A Russell. CA Cancer J Clin 2007
Times Cited: 1537







List of co-cited articles
799 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Effective communication in the era of precision medicine: A pilot intervention with low health literacy patients to improve genetic counseling communication.
Galen Joseph, Robin Lee, Rena J Pasick, Claudia Guerra, Dean Schillinger, Sara Rubin. Eur J Med Genet 2019
18
5

Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance.
Marc D Schwartz, Claudine Isaacs, Kristi D Graves, Elizabeth Poggi, Beth N Peshkin, Christy Gell, Clinton Finch, Scott Kelly, Kathryn L Taylor, Lauren Perley. Cancer 2012
93
1

Modes of delivery of genetic testing services and the uptake of cancer risk management strategies in BRCA1 and BRCA2 carriers.
T Pal, J-H Lee, A Besharat, Z Thompson, A N A Monteiro, C Phelan, J M Lancaster, K Metcalfe, T A Sellers, S Vadaparampil,[...]. Clin Genet 2014
23
4

Trends in use of bilateral prophylactic mastectomy vs high-risk surveillance in unaffected carriers of inherited breast cancer syndromes in the Inherited Cancer Registry (ICARE).
Danielle A Henry, Marie C Lee, Deanna Almanza, Kamran A Ahmed, Weihong Sun, David C Boulware, Christine Laronga. Breast Cancer Res Treat 2019
9
11

Knowledge, attitudes, and beliefs of Arab-American women regarding inherited cancer risk.
Suzanne Mellon, Jacqueline Gauthier, Michelle Cichon, Adnan Hammad, Michael S Simon. J Genet Couns 2013
23
4

Breast Cancer Risk Reduction Decisions of the BRCA-Positive Patient: An Observational Study at a Single Institution.
Dana Johns, Jay Agarwal, Layla Anderson, Jian Ying, Wendy Kohlmann. J Womens Health (Larchmt) 2017
7
14

A single visit multidisciplinary model for managing patients with mutations in moderate and high-risk genes in a community practice setting.
Michael P O'Leary, Bryan S Goldner, Sridevi Abboy, Philip D Mercado, Hong Yoon Plurad. Fam Cancer 2018
1
100

Awareness of endometrial cancer risk and compliance with screening in hereditary nonpolyposis colorectal cancer.
Zohreh Ketabi, Berit J Mosgaard, Anne-Marie Gerdes, Steen Ladelund, Inge T Bernstein. Obstet Gynecol 2012
16
6

Comparative Effectiveness of Two Interventions to Increase Colorectal Cancer Screening for Those at Increased Risk Based on Family History: Results of a Randomized Trial.
Electra D Paskett, Brittany M Bernardo, Gregory S Young, Mira L Katz, Paul L Reiter, Cathy M Tatum, Jill M Oliveri, Cecilia R DeGraffinreid, Darrell Mason Gray, Rachel Pearlman,[...]. Cancer Epidemiol Biomarkers Prev 2020
4
25

Racism and Health II: A Needed Research Agenda for Effective Interventions.
David R Williams, Selina A Mohammed. Am Behav Sci 2013
73
1

Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristics.
Claire Julian-Reynier, Anne-Déborah Bouhnik, Emanuelle Mouret-Fourme, Marion Gauthier-Villars, Pascaline Berthet, Christine Lasset, Jean-Pierre Fricker, Olivier Caron, Paul Gesta, Elisabeth Luporsi,[...]. Genet Med 2010
28
3

Patient and medical barriers preclude uptake of tamoxifen preventative therapy in women with a strong family history.
Anita R Skandarajah, Susan Thomas, Kylie Shackleton, Laura Chin-Lenn, Geoffrey J Lindeman, G Bruce Mann. Breast 2017
8
12

Impact of genetic testing on endometrial cancer risk-reducing practices in women at risk for Lynch syndrome.
Matthew B Yurgelun, Rowena Mercado, Margery Rosenblatt, Monica Dandapani, Wendy Kohlmann, Peggy Conrad, Amie Blanco, Kristen M Shannon, Daniel C Chung, Jonathan Terdiman,[...]. Gynecol Oncol 2012
19
5

Catalysts towards cancer risk management action: A longitudinal study of reproductive-aged women with BRCA1/2 mutations.
Allison Werner-Lin, Anne L Ersig, Rebecca Mueller, Jennifer L Young, Lindsey M Hoskins, Ria Desai, Mark H Greene. J Psychosoc Oncol 2018
7
14

Adherence to Recommended Risk Management among Unaffected Women with a BRCA Mutation.
Adam H Buchanan, Corrine I Voils, Joellen M Schildkraut, Catherine Fine, Nora K Horick, P Kelly Marcom, Kristi Wiggins, Celette Sugg Skinner. J Genet Couns 2017
11
9


Patient-reported disease knowledge and educational needs in Lynch syndrome: findings of an interactive multidisciplinary patient conference.
Sarah A Bannon, Maureen Mork, Eduardo Vilar, Susan K Peterson, Karen Lu, Patrick M Lynch, Miguel A Rodriguez-Bigas, Yiqian Nancy You. Hered Cancer Clin Pract 2014
13
7

The influence of Malay cultural beliefs on breast cancer screening and genetic testing: A focus group study.
Tarryn Shaw, Diana Ishak, Désirée Lie, Sapna Menon, Eliza Courtney, Shao-Tzu Li, Joanne Ngeow. Psychooncology 2018
12
8

Gynecologic cancer screening and communication with health care providers in women with Lynch syndrome.
A M Burton-Chase, S R Hovick, C C Sun, S Boyd-Rogers, P M Lynch, K H Lu, S K Peterson. Clin Genet 2014
13
7


Impact of clinical registries on quality of patient care and clinical outcomes: A systematic review.
Dewan Md Emdadul Hoque, Varuni Kumari, Masuma Hoque, Rasa Ruseckaite, Lorena Romero, Sue M Evans. PLoS One 2017
69
1

Information exchange between patients with Lynch syndrome and their genetic and non-genetic health professionals: whose responsibility?
Kirsten F L Douma, Fonnet E Bleeker, Niki M Medendorp, Emmelyn A J Croes, Ellen M A Smets. J Community Genet 2019
4
25

Exploring factors that impact uptake of risk-reducing bilateral salpingo-oophorectomy (RRBSO) in high-risk women.
Martha Hickey, Ines Rio, Alison Trainer, Jennifer L Marino, C David Wrede, Michelle Peate. Menopause 2020
9
11

Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.
Deborah Cragun, Anne Weidner, Courtney Lewis, Devon Bonner, Jongphil Kim, Susan T Vadaparampil, Tuya Pal. Cancer 2017
89
1

Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
Enrique Quintero, Marta Carrillo, Antonio Z Gimeno-García, Manuel Hernández-Guerra, David Nicolás-Pérez, Inmaculada Alonso-Abreu, Maria Luisa Díez-Fuentes, Víctor Abraira. Gastroenterology 2014
37
2

SMART on FHIR Genomics: facilitating standardized clinico-genomic apps.
Gil Alterovitz, Jeremy Warner, Peijin Zhang, Yishen Chen, Mollie Ullman-Cullere, David Kreda, Isaac S Kohane. J Am Med Inform Assoc 2015
61
1

Genetic testing and personalized ovarian cancer screening: a survey of public attitudes.
Susanne F Meisel, Belinda Rahman, Lucy Side, Lindsay Fraser, Sue Gessler, Anne Lanceley, Jane Wardle. BMC Womens Health 2016
17
5

Women's preferences for cancer risk management strategies in Lynch syndrome.
Charlotte C Sun, Larissa A Meyer, Molly S Daniels, Diane C Bodurka, Denise R Nebgen, Allison M Burton-Chase, Karen H Lu, Susan K Peterson. Gynecol Oncol 2019
6
16


Worldwide Practice Patterns in Lynch Syndrome Diagnosis and Management, Based on Data From the International Mismatch Repair Consortium.
Jennifer Y Pan, Robert W Haile, Allyson Templeton, Finlay Macrae, FeiFei Qin, Vandana Sundaram, Uri Ladabaum. Clin Gastroenterol Hepatol 2018
7
14

The Effects of Race and Racial Concordance on Patient-Physician Communication: A Systematic Review of the Literature.
Megan Johnson Shen, Emily B Peterson, Rosario Costas-Muñiz, Migda Hunter Hernandez, Sarah T Jewell, Konstantina Matsoukas, Carma L Bylund. J Racial Ethn Health Disparities 2018
154
1



Significant differences among physician specialties in management recommendations of BRCA1 mutation carriers.
S U Dhar, H P Cooper, T Wang, B Parks, S A Staggs, S Hilsenbeck, S E Plon. Breast Cancer Res Treat 2011
22
4

Bridging the Gap: Holistic Review to Increase Diversity in Graduate Medical Education.
Omowunmi Aibana, Jennifer L Swails, Renee J Flores, LaTanya Love. Acad Med 2019
45
2

Decision making for breast cancer prevention among women at elevated risk.
Tasleem J Padamsee, Celia E Wills, Lisa D Yee, Electra D Paskett. Breast Cancer Res 2017
30
3


Healthcare system distrust and the breast cancer continuum of care.
Morgane C Mouslim, Renee M Johnson, Lorraine T Dean. Breast Cancer Res Treat 2020
9
11

Suboptimal Adherence in Clinical Practice to Guidelines Recommendation to Screen for Lynch Syndrome.
A Jain, L Shafer, H Rothenmund, C A Kim, J Samadder, S Gupta, H Singh. Dig Dis Sci 2019
5
20

Misrepresenting Race - The Role of Medical Schools in Propagating Physician Bias.
Christina Amutah, Kaliya Greenidge, Adjoa Mante, Michelle Munyikwa, Sanjna L Surya, Eve Higginbotham, David S Jones, Risa Lavizzo-Mourey, Dorothy Roberts, Jennifer Tsai,[...]. N Engl J Med 2021
29
3

Do Eligibility Criteria for Ductal Carcinoma In Situ (DCIS) Active Surveillance Trials Identify Patients at Low Risk for Upgrade to Invasive Carcinoma?
Tawakalitu O Oseni, Barbara L Smith, Constance D Lehman, Charmi A Vijapura, Niveditha Pinnamaneni, Manisha Bahl. Ann Surg Oncol 2020
6
16

Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007.
Katharine Yao, Andrew K Stewart, David J Winchester, David P Winchester. Ann Surg Oncol 2010
184
1

Risk of Contralateral Breast Cancer in Women with Ductal Carcinoma In Situ Associated with Synchronous Ipsilateral Lobular Carcinoma In Situ.
Megan E Miller, Shirin Muhsen, Emily C Zabor, Jessica Flynn, Cristina Olcese, Dilip Giri, Kimberly J Van Zee, Melissa Pilewskie. Ann Surg Oncol 2019
2
50

Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment.
Todd M Tuttle, Elizabeth B Habermann, Erin H Grund, Todd J Morris, Beth A Virnig. J Clin Oncol 2007
459
1




Pathologic variables predictive of breast events in patients with ductal carcinoma in situ.
Edwin R Fisher, Stephanie R Land, Reda S Saad, Bernard Fisher, D Lawrence Wickerham, Meihua Wang, Joseph P Costantino, Norman Wolmark. Am J Clin Pathol 2007
49
2

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.
B Fisher, J Dignam, N Wolmark, D L Wickerham, E R Fisher, E Mamounas, R Smith, M Begovic, N V Dimitrov, R G Margolese,[...]. Lancet 1999
700
1



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.